Global Naldemedine Market Growth 2025-2031

December 2025 | 79 pages | ID: G2449581744EN
LP Information

Abstracts

The global Naldemedine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Naldemedine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Naldemedine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Naldemedine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Naldemedine players cover Shionogi, Purdue Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Naldemedine Industry Forecast” looks at past sales and reviews total world Naldemedine sales in 2024, providing a comprehensive analysis by region and market sector of projected Naldemedine sales for 2025 through 2031. With Naldemedine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Naldemedine industry.

This Insight Report provides a comprehensive analysis of the global Naldemedine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Naldemedine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Naldemedine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Naldemedine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Naldemedine.

This report presents a comprehensive overview, market shares, and growth opportunities of Naldemedine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Self-production API
• Outsourcing of API

Segmentation by Application:

• Hospital
• Clinic
• Drug Center
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Shionogi
• Purdue Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Naldemedine market?

What factors are driving Naldemedine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Naldemedine market opportunities vary by end market size?

How does Naldemedine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Naldemedine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Naldemedine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Naldemedine by Country/Region, 2020, 2024 & 2031
2.2 Naldemedine Segment by Type
  2.2.1 Self-production API
  2.2.2 Outsourcing of API
2.3 Naldemedine Sales by Type
  2.3.1 Global Naldemedine Sales Market Share by Type (2020-2025)
  2.3.2 Global Naldemedine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Naldemedine Sale Price by Type (2020-2025)
2.4 Naldemedine Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Drug Center
  2.4.4 Others
2.5 Naldemedine Sales by Application
  2.5.1 Global Naldemedine Sale Market Share by Application (2020-2025)
  2.5.2 Global Naldemedine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Naldemedine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Naldemedine Breakdown Data by Company
  3.1.1 Global Naldemedine Annual Sales by Company (2020-2025)
  3.1.2 Global Naldemedine Sales Market Share by Company (2020-2025)
3.2 Global Naldemedine Annual Revenue by Company (2020-2025)
  3.2.1 Global Naldemedine Revenue by Company (2020-2025)
  3.2.2 Global Naldemedine Revenue Market Share by Company (2020-2025)
3.3 Global Naldemedine Sale Price by Company
3.4 Key Manufacturers Naldemedine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Naldemedine Product Location Distribution
  3.4.2 Players Naldemedine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NALDEMEDINE BY GEOGRAPHIC REGION

4.1 World Historic Naldemedine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Naldemedine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Naldemedine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Naldemedine Market Size by Country/Region (2020-2025)
  4.2.1 Global Naldemedine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Naldemedine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Naldemedine Sales Growth
4.4 APAC Naldemedine Sales Growth
4.5 Europe Naldemedine Sales Growth
4.6 Middle East & Africa Naldemedine Sales Growth

5 AMERICAS

5.1 Americas Naldemedine Sales by Country
  5.1.1 Americas Naldemedine Sales by Country (2020-2025)
  5.1.2 Americas Naldemedine Revenue by Country (2020-2025)
5.2 Americas Naldemedine Sales by Type (2020-2025)
5.3 Americas Naldemedine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Naldemedine Sales by Region
  6.1.1 APAC Naldemedine Sales by Region (2020-2025)
  6.1.2 APAC Naldemedine Revenue by Region (2020-2025)
6.2 APAC Naldemedine Sales by Type (2020-2025)
6.3 APAC Naldemedine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Naldemedine by Country
  7.1.1 Europe Naldemedine Sales by Country (2020-2025)
  7.1.2 Europe Naldemedine Revenue by Country (2020-2025)
7.2 Europe Naldemedine Sales by Type (2020-2025)
7.3 Europe Naldemedine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Naldemedine by Country
  8.1.1 Middle East & Africa Naldemedine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Naldemedine Revenue by Country (2020-2025)
8.2 Middle East & Africa Naldemedine Sales by Type (2020-2025)
8.3 Middle East & Africa Naldemedine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Naldemedine
10.3 Manufacturing Process Analysis of Naldemedine
10.4 Industry Chain Structure of Naldemedine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Naldemedine Distributors
11.3 Naldemedine Customer

12 WORLD FORECAST REVIEW FOR NALDEMEDINE BY GEOGRAPHIC REGION

12.1 Global Naldemedine Market Size Forecast by Region
  12.1.1 Global Naldemedine Forecast by Region (2026-2031)
  12.1.2 Global Naldemedine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Naldemedine Forecast by Type (2026-2031)
12.7 Global Naldemedine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Shionogi
  13.1.1 Shionogi Company Information
  13.1.2 Shionogi Naldemedine Product Portfolios and Specifications
  13.1.3 Shionogi Naldemedine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Shionogi Main Business Overview
  13.1.5 Shionogi Latest Developments
13.2 Purdue Pharma
  13.2.1 Purdue Pharma Company Information
  13.2.2 Purdue Pharma Naldemedine Product Portfolios and Specifications
  13.2.3 Purdue Pharma Naldemedine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Purdue Pharma Main Business Overview
  13.2.5 Purdue Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Naldemedine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Naldemedine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Self-production API
Table 4. Major Players of Outsourcing of API
Table 5. Global Naldemedine Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Naldemedine Sales Market Share by Type (2020-2025)
Table 7. Global Naldemedine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Naldemedine Revenue Market Share by Type (2020-2025)
Table 9. Global Naldemedine Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Naldemedine Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Naldemedine Sale Market Share by Application (2020-2025)
Table 12. Global Naldemedine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Naldemedine Revenue Market Share by Application (2020-2025)
Table 14. Global Naldemedine Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Naldemedine Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Naldemedine Sales Market Share by Company (2020-2025)
Table 17. Global Naldemedine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Naldemedine Revenue Market Share by Company (2020-2025)
Table 19. Global Naldemedine Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Naldemedine Producing Area Distribution and Sales Area
Table 21. Players Naldemedine Products Offered
Table 22. Naldemedine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Naldemedine Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Naldemedine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Naldemedine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Naldemedine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Naldemedine Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Naldemedine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Naldemedine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Naldemedine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Naldemedine Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Naldemedine Sales Market Share by Country (2020-2025)
Table 35. Americas Naldemedine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Naldemedine Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Naldemedine Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Naldemedine Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Naldemedine Sales Market Share by Region (2020-2025)
Table 40. APAC Naldemedine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Naldemedine Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Naldemedine Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Naldemedine Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Naldemedine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Naldemedine Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Naldemedine Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Naldemedine Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Naldemedine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Naldemedine Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Naldemedine Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Naldemedine
Table 52. Key Market Challenges & Risks of Naldemedine
Table 53. Key Industry Trends of Naldemedine
Table 54. Naldemedine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Naldemedine Distributors List
Table 57. Naldemedine Customer List
Table 58. Global Naldemedine Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Naldemedine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Naldemedine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Naldemedine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Naldemedine Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Naldemedine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Naldemedine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Naldemedine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Naldemedine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Naldemedine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Naldemedine Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Naldemedine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Naldemedine Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Naldemedine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Shionogi Basic Information, Naldemedine Manufacturing Base, Sales Area and Its Competitors
Table 73. Shionogi Naldemedine Product Portfolios and Specifications
Table 74. Shionogi Naldemedine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Shionogi Main Business
Table 76. Shionogi Latest Developments
Table 77. Purdue Pharma Basic Information, Naldemedine Manufacturing Base, Sales Area and Its Competitors
Table 78. Purdue Pharma Naldemedine Product Portfolios and Specifications
Table 79. Purdue Pharma Naldemedine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Purdue Pharma Main Business
Table 81. Purdue Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Naldemedine
Figure 2. Naldemedine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Naldemedine Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Naldemedine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Naldemedine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Naldemedine Sales Market Share by Country/Region (2024)
Figure 10. Naldemedine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Self-production API
Figure 12. Product Picture of Outsourcing of API
Figure 13. Global Naldemedine Sales Market Share by Type in 2025
Figure 14. Global Naldemedine Revenue Market Share by Type (2020-2025)
Figure 15. Naldemedine Consumed in Hospital
Figure 16. Global Naldemedine Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Naldemedine Consumed in Clinic
Figure 18. Global Naldemedine Market: Clinic (2020-2025) & (K Pcs)
Figure 19. Naldemedine Consumed in Drug Center
Figure 20. Global Naldemedine Market: Drug Center (2020-2025) & (K Pcs)
Figure 21. Naldemedine Consumed in Others
Figure 22. Global Naldemedine Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Naldemedine Sale Market Share by Application (2024)
Figure 24. Global Naldemedine Revenue Market Share by Application in 2025
Figure 25. Naldemedine Sales by Company in 2025 (K Pcs)
Figure 26. Global Naldemedine Sales Market Share by Company in 2025
Figure 27. Naldemedine Revenue by Company in 2025 ($ millions)
Figure 28. Global Naldemedine Revenue Market Share by Company in 2025
Figure 29. Global Naldemedine Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Naldemedine Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Naldemedine Sales 2020-2025 (K Pcs)
Figure 32. Americas Naldemedine Revenue 2020-2025 ($ millions)
Figure 33. APAC Naldemedine Sales 2020-2025 (K Pcs)
Figure 34. APAC Naldemedine Revenue 2020-2025 ($ millions)
Figure 35. Europe Naldemedine Sales 2020-2025 (K Pcs)
Figure 36. Europe Naldemedine Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Naldemedine Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Naldemedine Revenue 2020-2025 ($ millions)
Figure 39. Americas Naldemedine Sales Market Share by Country in 2025
Figure 40. Americas Naldemedine Revenue Market Share by Country (2020-2025)
Figure 41. Americas Naldemedine Sales Market Share by Type (2020-2025)
Figure 42. Americas Naldemedine Sales Market Share by Application (2020-2025)
Figure 43. United States Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Naldemedine Sales Market Share by Region in 2025
Figure 48. APAC Naldemedine Revenue Market Share by Region (2020-2025)
Figure 49. APAC Naldemedine Sales Market Share by Type (2020-2025)
Figure 50. APAC Naldemedine Sales Market Share by Application (2020-2025)
Figure 51. China Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 55. India Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Naldemedine Sales Market Share by Country in 2025
Figure 59. Europe Naldemedine Revenue Market Share by Country (2020-2025)
Figure 60. Europe Naldemedine Sales Market Share by Type (2020-2025)
Figure 61. Europe Naldemedine Sales Market Share by Application (2020-2025)
Figure 62. Germany Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 63. France Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Naldemedine Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Naldemedine Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Naldemedine Sales Market Share by Application (2020-2025)
Figure 70. Egypt Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Naldemedine Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Naldemedine in 2025
Figure 76. Manufacturing Process Analysis of Naldemedine
Figure 77. Industry Chain Structure of Naldemedine
Figure 78. Channels of Distribution
Figure 79. Global Naldemedine Sales Market Forecast by Region (2026-2031)
Figure 80. Global Naldemedine Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Naldemedine Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Naldemedine Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Naldemedine Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Naldemedine Revenue Market Share Forecast by Application (2026-2031)